SUNLIGHT
May 04, 2023•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Talking 3rd-line treatment of metastatic colon cancer. Tipiracil-trifluridine + bevacizuamb vs. tipiracil-trifluridine alone. And a bit on the theory of "bevacizumab beyond progression."
SUNLIGHT: https://www.nejm.org/doi/full/10.1056/NEJMoa2214963
For the best experience, listen in Metacast app for iOS or Android